Healthcare company recalls these 3 injectable drugs
Baxter International has issued a voluntary recall for three injectable drugs due to potential contamination with fiberglass and stainless steel particles. The affected products, which include nutrition and electrolyte solutions, pose risks of blood clots, organ injury, and inflammation if administered.
Why it matters
Medical product recalls are critical for patient safety, as contaminated injectables can lead to life-threatening complications in hospital and home-care settings.
Hear this story Multiple injectable drugs from the same company have been recalled over potential fiberglass and metal contamination.
Baxter International Inc. voluntarily recalled two injections used to provide nutrition, water and electrolytes to patients. A third injectable, an anticoagulant, or substance used to slow blood clotting, was also recalled, but only affected one patient.
The medication solutions could be contaminated with fiberglass or stainless steel particles, according to Food and Drug Administration notices published Aug. 25 and Aug. 26.
Injecting these medications could result in blockages, clotting issues and tissue or organ injury, according to the notices. While the supplies were sent mostly to healthcare facilities and distributors in several states, they could also be in at-home healthcare settings, per the FDA.
USA TODAY contacted Baxter for comment Aug. 27, but has not received a response.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in